Role of therapeutic apheresis in the treatment of pediatric kidney diseases

[1]  P. Srivaths,et al.  Tandem plasmapheresis and continuous kidney replacement treatment in pediatric patients , 2020, Pediatric Nephrology.

[2]  S. Jang,et al.  Use of angiotensin converting enzyme inhibitors in patients receiving therapeutic plasma exchange with a centrifuge‐based apheresis system , 2020, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[3]  P. Srivaths,et al.  Therapeutic plasma exchange: single-center experience in children with kidney disorders , 2020, Pediatric Nephrology.

[4]  R. Raina,et al.  Extracorporeal Therapies in the Treatment of Focal Segmental Glomerulosclerosis , 2020, Blood Purification.

[5]  A. Levin,et al.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. , 2020, The New England journal of medicine.

[6]  Ranjit S. Chima,et al.  Complement blockade for TA-TMA: lessons learned from large pediatric cohort treated with eculizumab. , 2020, Blood.

[7]  G. Öztürk,et al.  Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications , 2020, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[8]  T. Bunchman,et al.  Dextran-Sulfate Plasma Adsorption Lipoprotein Apheresis in Drug Resistant Primary Focal Segmental Glomerulosclerosis Patients: Results From a Prospective, Multicenter, Single-Arm Intervention Study , 2019, Front. Pediatr..

[9]  Ikuyo Yamaguchi,et al.  Impact of active antibody‐mediated rejection treatment on donor‐specific antibodies in pediatric kidney transplant recipients , 2019, Pediatric transplantation.

[10]  T. Blydt-Hansen,et al.  Risk factors associated with allograft failure in pediatric kidney transplant recipients with focal segmental glomerulosclerosis , 2019, Pediatric transplantation.

[11]  D. Hooper,et al.  LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients , 2019, Pediatric Nephrology.

[12]  D. Müller,et al.  Caplacizumab for relapsing thrombotic thrombocytopenic purpura , 2019, Pediatric Nephrology.

[13]  N. Dunbar,et al.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue , 2019, Journal of clinical apheresis.

[14]  Roy E. Smith,et al.  Hemostasis testing and therapeutic plasma exchange: Results of a practice survey , 2018, Journal of clinical apheresis.

[15]  T. Nakayama,et al.  Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis , 2018, Modern rheumatology.

[16]  R. Krance,et al.  Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  R. DeSimone,et al.  Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis , 2018, Journal of clinical apheresis.

[18]  T. Nguyen,et al.  Hybrid Extracorporeal Therapies as a Bridge to Pediatric Liver Transplantation* , 2018, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[19]  M. Paden,et al.  Epidemiology of therapeutic apheresis with a multidisciplinary approach at a high volume pediatric center , 2018, Journal of clinical apheresis.

[20]  B. Chavers,et al.  The effect of peri‐transplant plasmapheresis in the prevention of recurrent FSGS , 2018, Pediatric transplantation.

[21]  K. Nitta,et al.  Preoperative Low-Density Lipoprotein Apheresis for Preventing Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation , 2018, Journal of transplantation.

[22]  S. Chadban,et al.  The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis , 2018, Transplantation.

[23]  S. Tuchman,et al.  Results of early treatment for de novo donor‐specific antibodies in pediatric kidney transplant recipients in a cross‐sectional and longitudinal cohort , 2018, Pediatric transplantation.

[24]  W. Butt,et al.  Therapeutic Plasma Exchange in Critically Ill Children Requiring Intensive Care , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[25]  Ankit Sharma,et al.  Desensitisation strategies in high-risk children before kidney transplantation , 2018, Pediatric Nephrology.

[26]  David W. Johnson,et al.  Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  N. Sebire,et al.  Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation , 2017, Transplantation.

[28]  J. Raval,et al.  Apheresis education in pathology residency , 2017, Journal of clinical apheresis.

[29]  G. Ardissino,et al.  Plasma-exchange in pediatric patients: a single-center experience. , 2017, Minerva pediatrica.

[30]  I. Krause,et al.  Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years’ experience , 2016, Clinical transplantation.

[31]  Li Zhang,et al.  Therapeutic effect of double‐filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis , 2016, Journal of clinical apheresis.

[32]  Ahmed A. Al-Jaishi,et al.  The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series , 2016, BMC Nephrology.

[33]  S. Hingorani.  Renal Complications of Hematopoietic-Cell Transplantation. , 2016, The New England journal of medicine.

[34]  Ming-hui Zhao,et al.  Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic Microangiopathy , 2016, Medicine.

[35]  M. Stegall,et al.  Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. , 2016, The New England journal of medicine.

[36]  A. Webster,et al.  Interventions for renal vasculitis in adults , 2016, Nephrology.

[37]  W. Szczeklik,et al.  Effectiveness of plasmapheresis in ANCA clearance in patients with ANCA-associated vasculitides. , 2016, Przeglad lekarski.

[38]  G. Auzinger,et al.  High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. , 2016, Journal of hepatology.

[39]  C. Lacelle,et al.  Management of sensitized pediatric patients prior to renal transplantation , 2016, Pediatric Nephrology.

[40]  R. Sinha,et al.  Therapeutic plasma exchange in paediatric SLE: a case series from India , 2015, Lupus.

[41]  A. Sinha,et al.  Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndrome , 2015, Pediatric Nephrology.

[42]  L. Pape,et al.  Acute and chronic antibody-mediated rejection in pediatric kidney transplantation , 2015, Pediatric Nephrology.

[43]  A. Sinha,et al.  Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. , 2014, Kidney international.

[44]  M. Scully,et al.  Management of thrombotic thrombocytopenic purpura: current perspectives , 2014, Journal of blood medicine.

[45]  G. Espinosa,et al.  Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry". , 2014, Autoimmunity reviews.

[46]  S. Florman,et al.  Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients , 2014, Pediatric transplantation.

[47]  Kota Takahashi,et al.  ABO-incompatible living-donor pediatric kidney transplantation in Japan , 2014, Clinics.

[48]  S. Vesely,et al.  Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: Comparison of incidence, demographic and clinical features , 2013, Pediatric blood & cancer.

[49]  J. Goebel,et al.  Focal Segmental Glomerulosclerosis in Children: Multivariate Analysis Indicates That Donor Type Does Not Alter Recurrence Risk , 2013, Transplantation.

[50]  Kota Takahashi,et al.  ABO-incompatible kidney transplantation. , 2013, Transplantation reviews.

[51]  T. Ortel,et al.  Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A 20-Year Review from the Southern Network on Adverse Reactions (SONAR) , 2012, Seminars in Thrombosis & Hemostasis.

[52]  A. Kribben,et al.  Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[53]  D. Haffner,et al.  An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  Nathan T. James,et al.  Outcomes of ABO-Incompatible Kidney Transplantation in the United States , 2012, Transplantation.

[55]  G. Engelmann,et al.  Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[56]  R. Ettenger,et al.  Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation , 2011, Pediatric transplantation.

[57]  M. Konrad,et al.  Acute antibody-mediated rejection in paediatric renal transplant recipients , 2011, Pediatric Nephrology.

[58]  R. Balogun,et al.  Therapeutic apheresis: A review of complications and recommendations for Prevention and management , 2011, Journal of clinical apheresis.

[59]  R. Mohd,et al.  Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis. , 2010, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[60]  R. Montgomery,et al.  ABO Antibody Titer and Risk of Antibody‐Mediated Rejection in ABO‐Incompatible Renal Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[61]  D. Nochy,et al.  Comparison of Combination Plasmapheresis/IVIg/Anti‐CD20 Versus High‐Dose IVIg in the Treatment of Antibody‐Mediated Rejection , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[62]  T. Larson,et al.  Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis: Outcomes and Response to Therapy for Recurrence , 2009, Transplantation.

[63]  A. Kaplan.  Therapeutic plasma exchange: core curriculum 2008. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[64]  J. Tomaz,et al.  World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[65]  M. del Río,et al.  Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: A single center experience , 2008, Pediatric transplantation.

[66]  A. Kaplan,et al.  Predictable removal of anticardiolipin antibody by therapeutic plasma exchange (TPE) in catastrophic antiphospholipid antibody syndrome (CAPS). , 2008, Clinical nephrology.

[67]  M. David,et al.  Complications of apheresis in children , 2007, Transfusion.

[68]  D. Abramowicz,et al.  Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. , 2007, Journal of the American Society of Nephrology : JASN.

[69]  K. Kaneko,et al.  Plasma exchange combined with immunosuppressive treatment in a child with rapidly progressive IgA nephropathy , 2007, Pediatric Nephrology.

[70]  K. Tullus,et al.  Childhood vasculitis and plasma exchange , 2006, European Journal of Pediatrics.

[71]  G. Remuzzi,et al.  Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. , 2006, Blood.

[72]  G. Espinosa,et al.  Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. , 2006, Arthritis and rheumatism.

[73]  M. von Mach,et al.  Anticoagulation with low‐molecular‐weight heparin (dalteparin) in plasmapheresis therapy: initial experience , 2006, Transfusion.

[74]  B. Mcleod.  Rationales for therapeutic apheresis , 2005, Hematology.

[75]  Y. Kawasaki,et al.  Plasmapheresis therapy for rapidly progressive Henoch-Schönlein nephritis , 2004, Pediatric Nephrology.

[76]  D. Gipson,et al.  The differential effect of race among pediatric kidney transplant recipients with focal segmental glomerulosclerosis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[77]  M. Stegall,et al.  Plasma exchange conditioning for ABO‐incompatible renal transplantation , 2004, Journal of clinical apheresis.

[78]  M. Hattori,et al.  A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[79]  B. Krämer,et al.  Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[80]  M. Petri,et al.  Catastrophic Antiphospholipid Syndrome: Clues to the Pathogenesis from a Series of 80 Patients , 2001, Medicine.

[81]  M. Nagata,et al.  EFFECT OF PRE- AND POSTOPERATIVE PLASMAPHERESIS ON POSTTRANSPLANT RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN CHILDREN , 2001, Transplantation.

[82]  J. George,et al.  Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP) , 2001, Journal of clinical apheresis.

[83]  G. Ghiggeri,et al.  Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[84]  A. Rees,et al.  Anti-Glomerular Basement Membrane Disease , 2020, Definitions.

[85]  M. Hattori,et al.  Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[86]  R. J. Unwin,et al.  Kidney , 1969, The Journal of physiology.

[87]  J. Piette,et al.  Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients , 1998, Medicine.

[88]  F. Zacchello,et al.  Successful treatment of recurrent rejection in renal transplant patients with photopheresis. , 1998, Journal of the American Society of Nephrology : JASN.

[89]  D. Churchill,et al.  A Prospective Randomized Trial of Plasma Exchange as Additive Therapy in Idiopathic Crescentic Glomerulonephritis , 1992 .

[90]  J. Kelton,et al.  Comparison of Plasma Exchange With Plasma Infusion in the Treatment of Thrombotic Thrombocytopenia Purpura , 1992 .

[91]  D. Churchill,et al.  A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[92]  C. Pusey,et al.  Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. , 1991, Kidney international.

[93]  J. Kelton,et al.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. , 1991, The New England journal of medicine.

[94]  H. Wichmann,et al.  Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study. , 1988, Clinical nephrology.

[95]  F. Lai,et al.  Plasma exchange in patients with rapidly progressive idiopathic IgA nephropathy: a report of two cases and review of literature. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[96]  S. Yokoyama,et al.  Selective Removal of Low Density Lipoprotein by Plasmapheresis in Familial Hypercholesterolemia , 1985, Arteriosclerosis.

[97]  Christopher E. Smith.  United States , 1985, The Lancet.

[98]  R. Coppo,et al.  Plasma exchange in progressive primary IgA nephropathy. , 1985, The International journal of artificial organs.

[99]  E. Berkman,et al.  Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents. , 1980, Blood.